Results 71 to 80 of about 80,028,732 (285)
Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours [PDF]
Interleukin-7 (IL-7) plays an important role in the normal development and maintenance of the human immune system. Its effects are mediated via its receptor, IL-7R. Ligand-receptor engagement results in a cascade of phosphorylation events mediated by
Al-Rawi, M. A. A. +5 more
core
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman +9 more
wiley +1 more source
Mathematical model of naive T cell division and survival IL-7 thresholds
We develop a mathematical model to describe the homeostasis of naive T~cells in the peripheral immune system of ageing humans, incorporating thymic output and the availability of interleukin-7 (IL-7).
Carmen eMolina-Paris +3 more
doaj +1 more source
Cell proliferation in response to IL-7 (10ng/ml) and/or PHA (0.2mg/ml) was measured as CFSE dilution of CD8+ T-cells from (A) HCV- (n = 8) and (B) HCV+ individuals (n = 8), with markers indicating the proportion (%) of CFSElow (dividing) cells.
Angela M. Crawley (371040) +3 more
core +1 more source
ABSTRACT Background Latino children are projected to make up nearly one‐third of United States (US) children by 2060, and many of their caregivers speak Spanish. Prior survey research has documented communication difficulties for Spanish‐speaking caregivers of children with cancer, but contemporary qualitative data are limited.
Jenny Ruiz +6 more
wiley +1 more source
Evaluation of IL-2 and IL-7 expression in patients with prostate cancer
Background: Prostate cancer is a biologically heterogeneous disease which has become the fifth leading cause of cancer-related deaths in men worldwide. Interleukins (ILs) display required inflammation moderator.
Faezeh Namazi +3 more
doaj
Despite remarkable advances in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), relapsed cases are still a major challenge. Moreover, even successful cases often face long-term treatment-associated toxicities.
Perera, Yasser +13 more
core +1 more source
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad +9 more
wiley +1 more source
ABSTRACT Background Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.
Karen Schow Jensen +10 more
wiley +1 more source
Human CD4+ Memory T Cells Can Become CD4+IL-9+ T Cells [PDF]
Background: IL-9 is a growth factor for T- and mast-cells that is secreted by human Th2 cells. We recently reported that IL-4+TGF-β directs mouse CD4+CD25−CD62L+ T cells to commit to inflammatory IL-9 producing CD4+ T cells.
Popoola, Joyce +17 more
core +2 more sources

